Is CGC Worth Buying in 2026?

Canopy Growth Corporation Common Shares

STOCK MEDICINAL CHEMICALS & BOTANICAL PRODUCTS Updated 2026-06-07

Here’s whether Canopy Growth Corporation Common Shares (CGC) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.

🟡
Caution

Positives: 50-day MA is rising (+1.12% over 10 days); RSI 49 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); weak 1-year return of -24.8%. Currently 56.7% off its 52-week high. Score: -2/7.

Ready to act on this? 📈 Trade on Webull

CGC is trading below its 200-day MA ($1.20) — a key warning sign the longer-term trend is under pressure. An RSI of 48.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -24.8% compares to +24.4% for SPY (trailed the market by 49.2%). The current 56.7% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $7,518 today
vs. S&P 500 (SPY) — same period trailed market by 49.2%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($1.20)
Above 50-day MA ($1.08)
RSI(14) neutral zone (30–70) — currently 48.5
Positive return (-24.8%)
!Within 10% of period high (−56.7%)
Period Range $1.03
$0.84 $2.38
RSI (14) 48.5
0 · OversoldOverbought · 100

Key Metrics

Price$1.03
Period Return-24.8%
Period High$2.38
Period Low$0.84
Drawdown−56.7%
MA-50$1.08
MA-200$1.20
RSI (14)48.5
Avg Volume (30d)8.1M
vs. SPYtrailed by 49.2%
Return Rank#910 of 1245

Trade CGC

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers